Adaptive Biotechnologies (ADPT) EBIT Margin (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted EBIT Margin of 27.1% for Q1 2026, down 52.08% sequentially from 17.82% in Q4 2025, and up 2935.0% YoY from 0.89% in Q1 2025.
Adaptive Biotechnologies (ADPT) EBIT Margin (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 9 years of EBIT Margin data on file, last reported at 27.1% in Q1 2026.
- Quarterly EBIT Margin rose 2935.0% year-over-year to 27.1% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.82% (up 5984.0% YoY) and the FY2025 annual result came in at 20.62%, up 7021.0% from the prior year.
- EBIT Margin slipped to 27.1% in Q1 2026 per ADPT's latest filing, from 17.82% in the prior quarter.
- The five-year high for EBIT Margin was 10.95% in Q3 2025, with the low at 621.01% in Q2 2023.
- Average EBIT Margin over 5 years is 118.39%, with a median of 94.98% recorded in 2022.
- Year-over-year, EBIT Margin slumped 50076 bps in 2023 and surged 51146 bps in 2024.
- Adaptive Biotechnologies' EBIT Margin stood at 70.99% in 2022, then sank by 119 bps to 155.22% in 2023, then soared by 54 bps to 71.3% in 2024, then jumped by 75 bps to 17.82% in 2025, then slumped by 52 bps to 27.1% in 2026.
- Business Quant data shows ADPT's EBIT Margin at 27.1% in Q1 2026, 17.82% in Q4 2025, and 10.95% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 31.78% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -13.42% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.74% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 25.23% |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | -27.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.10% |
| Dec 31, 2025 | -17.82% |
| Sep 30, 2025 | 10.95% |
| Jun 30, 2025 | -42.52% |
| Mar 31, 2025 | -56.45% |
| Dec 31, 2024 | -71.30% |
| Sep 30, 2024 | -70.27% |
| Jun 30, 2024 | -109.56% |
| Mar 31, 2024 | -116.45% |
| Dec 31, 2023 | -155.22% |
| Sep 30, 2023 | -134.38% |
| Jun 30, 2023 | -621.01% |
| Mar 31, 2023 | -151.92% |
| Dec 31, 2022 | -70.99% |
| Sep 30, 2022 | -94.98% |
| Jun 30, 2022 | -120.25% |
| Mar 31, 2022 | -163.30% |
| Dec 31, 2021 | -162.39% |
| Sep 30, 2021 | -142.71% |
| Jun 30, 2021 | -129.24% |